Both generic and brand-name drug manufacturers could promote measures to distinguish trustworthy GLP-1 products from substandard or unsafe alternatives.
For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds.
Unfortunately, a number of unscrupulous companies have sought to capitalize on the growing demand for GLP-1s in ways putting patients at serious risk of harm. Many of these operations — including telehealth services and online pharmacies — are making their own unapproved versions of these medicines and leading patients to believe they’re buying the genuine article.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Patients Can’t Wait for Federal Action on Knock-Off Medicines
Sally C. Pipes
Both generic and brand-name drug manufacturers could promote measures to distinguish trustworthy GLP-1 products from substandard or unsafe alternatives.
For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds.
Unfortunately, a number of unscrupulous companies have sought to capitalize on the growing demand for GLP-1s in ways putting patients at serious risk of harm. Many of these operations — including telehealth services and online pharmacies — are making their own unapproved versions of these medicines and leading patients to believe they’re buying the genuine article.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.